Mesenchymal stem cells (MSC) exhibit a high self‐renewal capacity, multilineage
differentiation potential and immunomodulatory properties. This set of exceptional features …

Here, the literature was reviewed to evaluate whether a population of mesenchymal stromal
cells derived from Wharton's jelly cells (WJCs) is a primitive stromal population. A clear case …

Cells isolated from Wharton's jelly, referred to as umbilical cord matrix stromal (UCMS) cells,
adhere to a tissue-culture plastic substrate, express mesenchymal stromal cell (MSC) …

Cells in the umbilical cord stroma have gained attention in recent years; however,
differentiation to certain lineages in humans has been demonstrated in few studies. Unlike …

The human umbilical cord that originates from the embryo is an extra-embryonic membrane
and the Wharton's jelly within it is a rich source of stem cells (hWJSCs). It is not definitely …

Human umbilical cord (UC) has been a tissue of increasing interest in recent years. Many
groups have shown the stem cell potency of stromal cells isolated from the human UC …

In recent years there seems to be an unbounded interest concerning mesenchymal stem
cells (MSCs). This is mainly attributed to their exciting characteristics including long-term ex …

Stem cells are the next frontier in medicine. Stem cells are thought to have great therapeutic
and biotechnological potential. This will not only to replace damaged or dysfunctional cells …

Mesenchymal stem cells (MSCs) from bone marrow, adult organs and fetuses face the
disadvantages of invasive isolation, limited cell numbers and ethical constraints while …

This review focuses on the therapeutic potential of stem cells harvested from the Wharton's
Jelly of the human umbilical cord. Recently, investigators have found that a potent stem cell …